White Paper — Sponsored Content

How to Ensure a Holistic Process Characterization in Biotech & Pharma

How to Ensure a Holistic Process Characterization in Biotech & Pharma

Constant, reliable product quality is a must for pharmaceutical and biopharmaceutical manufacturing. Regulatory authorities require drug manufacturers to consistently deliver product quality through validated processes in order to achieve product approval. Process characterization is a central cornerstone and the first stage of process validation (PV). Failing to efficiently plan and execute activities on that stage leads to increased time-to-market.  A successful process characterization study (PCS) is key to reduce time-to market of any pharmaceutical and biopharmaceutical product. This can be achieved by following a 7-step model that starts with a process validation plan and leads to an integrated process model and overall control strategy. Learn more in this white paper.

Download White Paper


To download this white paper, complete the form below. Once submitted, you will receive a link via the email you provided to download the white paper.

Name
Company Type
Address

By completing this form, you consent to have your information provided to the third-party sponsor of this content and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you . ISPE will store your information in a secure environment and may use your information to provide information about relevant products, services, and other opportunities which may be of interest to you. You may unsubscribe from these ISPE communications at any time. For more information or to unsubscribe, review our Privacy Policy or contact us at ask@ispe.org.